Zobrazeno 1 - 10
of 2 882
pro vyhledávání: '"common terminology criteria for adverse events"'
Publikováno v:
Patient Related Outcome Measures, Vol Volume 13, Pp 249-258 (2022)
Lori M Minasian,1 Ann O’Mara,2,3 Sandra A Mitchell4 1Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA; 2Consultant, ICF, Fairfax, VA, USA; 3Consultant to Division of Cancer Prevention, National Cancer Institute, Bethesda,
Externí odkaz:
https://doaj.org/article/848768f700024124be634928551f835d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Michael J. Hassett, Sandra Wong, Raymond U. Osarogiagbon, Jessica Bian, Don S. Dizon, Hannah Hazard Jenkins, Hajime Uno, Christine Cronin, Deborah Schrag, SIMPRO Co-Investigators
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-15 (2022)
Abstract Background Many cancer patients experience high symptom burden. Healthcare in the USA is reactive, not proactive, and doctor-patient communication is often suboptimal. As a result, symptomatic patients may suffer between clinic visits. In re
Externí odkaz:
https://doaj.org/article/5ce5a410bf42457ab9cd88b98ace1cf4
Autor:
Robert Knoerl, Emanuele Mazzola, Sandra A. Mitchell, Fangxin Hong, Elahe Salehi, Nadine McCleary, Jennifer A. Ligibel, Kaitlen Reyes, Donna L. Berry
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 5, Iss 1, Pp 1-11 (2021)
Abstract Background Timely detection of chemotherapy-induced peripheral neuropathy (CIPN) is critical to effectively tailor chemotherapy dose levels and offer supportive care. The purpose of this secondary analysis was to determine the reliability an
Externí odkaz:
https://doaj.org/article/97b7f97966654f348c1827021ee5ef37
Autor:
Lisa M. Wintner, Johannes M. Giesinger, Monika Sztankay, Andrew Bottomley, Bernhard Holzner, on behalf of the EORTC Quality of Life Group
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-7 (2020)
Abstract Background In oncology, detection and tracking of adverse events are of top priority and rely mostly on the Common Terminology Criteria for Adverse Events (CTCAE). Besides, clinical trials use as well patient-reported outcomes (PROs) to asse
Externí odkaz:
https://doaj.org/article/1e18040c2fd24b7e972a95d215e244b0
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 2, Pp 491-496 (2020)
Digital patient monitoring gains importance for quality of clinical cancer care. Our case report provides insight into usability and acceptance of a smartphone app for monitoring of electronically captured patient-reported outcomes in patients underg
Externí odkaz:
https://doaj.org/article/6ffd2dbdeda84bb6b8f8d1226e47a00d
Autor:
O. Honma, C. Watanabe, H. Fukuchimoto, J. Kashiwazaki, M. Tateba, S. Wagatsuma, K. Ogata, K. Maki, H. Sonou, K. Shiga, E. Otsuka, M. Hiruta, Y. Hirasawa, M. Hosonuma, M. Murayama, Y. Narikawa, H. Toyoda, T. Tsurui, A. Kuramasu, M. Kin, Y. Kubota, T. Sambe, A. Horiike, H. Ishida, K. Shimada, M. Umeda, T. Tsunoda, K. Yoshimura
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Proper management of adverse events is crucial for the safe and effective implementation of anticancer drug treatment. Showa University Hospital uses our interview sheet (assessment and risk control [ARC] sheet) for the accurate evaluatio
Externí odkaz:
https://doaj.org/article/4fbdcae284484c808d7289723a8c56ba
Autor:
Angelo M Bergamo, Kevin Kauweloa, Gregory Gan, Zheng Shi, Janeen Daniels, Richard Crownover, Ganesh Narayanasamy, Sotirios Stathakis, Panayiotis Mavroidis, Niko Papanikolaou, Alonso Gutierrez
Publikováno v:
Journal of Medical Physics, Vol 44, Iss 3, Pp 185-190 (2019)
Background: The prevention of radiation-induced liver disease (RILD) is very significant in ensuring a safe radiation treatment and high quality of life. Aims and Objectives: The purpose of this study is to investigate the correlation of physical and
Externí odkaz:
https://doaj.org/article/2091db976db345899a6e227cc7d2bea5
Autor:
Maud le Guyader, Daniel Lam Cham Kee, Mathieu Gautier, Marie-Eve Chand-Fouche, Renaud Schiappa, Brice Thamphya, Jean-Michel Hannoun-Levi
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 32, Iss, Pp 15-23 (2022)
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology
Highlights • Brachytherapy boost is a standard of care for locally advanced cervical cancer. • High-dose-rate brachytherapy (HDR-BT) boost procedure is not standardized. • The number of implants, fractions, doses and imaging differ in literatur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0e241555be0dbedb8ff97b894cac2d8
https://doi.org/10.1016/j.ctro.2021.10.005
https://doi.org/10.1016/j.ctro.2021.10.005